logo
Select company
Select metric
-152.23%Free Cash Flow Yield
VS
Market
3
Sector
10
Industry
13
History
75
$ 2.13Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information

Ticker

INM

Company Name

INMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INMED PHARMACEUTICALS INC - Free Cash Flow Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INM - FCF Yield Historical data
DateFree Cash FlowFree Cash Flow YieldMarket Capitalization
6/30/2025$ -7.77M-152.23%$ 5.1M
3/31/2025$ -7.02M-254.96%$ 2.75M
12/31/2024$ -7.29M-188.78%$ 3.86M
9/30/2024$ -6.65M-182.25%$ 3.65M
6/30/2024$ -7M-221.25%$ 3.16M
3/31/2024$ -6.66M-298.33%$ 2.23M
12/31/2023$ -6.51M-301.99%$ 2.16M
9/30/2023$ -7.36M-363.03%$ 2.03M
6/30/2023$ -7.45M-319.61%$ 2.33M
3/31/2023$ -10.8M-279.76%$ 3.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) FCF Yield stands at 0%.
  • Over the past 5 years, INMED PHARMACEUTICALS INC's average FCF Yield has been -237.21%.
  • The median FCF Yield for INMED PHARMACEUTICALS INC during this period was -254.96%
  • INMED PHARMACEUTICALS INC reached its highest FCF Yield over the past 5 years at -57.38%.
  • The lowest FCF Yield recorded by INMED PHARMACEUTICALS INC in the same timeframe -584.61%

INMED PHARMACEUTICALS INC's FCF Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Yield Benchmarks
CompanyFCF Yield
NBY : NOVABAY PHARMACEUTICALS INC -208.62%XBIO : XENETIC BIOSCIENCES INC -58.54%SPRB : SPRUCE BIOSCIENCES INC -1044.43%CPHI : CHINA PHARMA HOLDINGS INC 7.48%ONCO : ONCONETIX INC -114.74%SXTP : 60 DEGREES PHARMACEUTICALS INC -116.61%BNBX : APPLIED DNA SCIENCES INC -252.29%ADTX : ADITXT INC -441.09%CDT : CONDUIT PHARMACEUTICALS INC -249.67%GTBP : GT BIOPHARMA INC -202.02%

Definition of Free Cash Flow Yield

[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
FCF / Market Cap
(=) FCF Yield
FCF Yield for INMED PHARMACEUTICALS INC is calculated as follows: FCF [ $ 0 ] / Market Cap [ $ 20.83M ]
(=) FCF Yield [ 0% ]

INM - Free Cash Flow Yield, Last 5 years

-584.61%

Minimum

Sep 30, 2022

-57.38%

Maximum

Jun 30, 2021

-237.21%

Average

-254.96%

Median

FCF Yield Benchmark Analysis

The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.62% with a standard deviation of 11.36%.
The following table provides additional summary stats:
FCF Yield in the Market:
filtered constituents3.58K
min-33.87%
max37.55%
average1.62%
median3.25%
std11.36%